Home › NDC Lookup › RxCUI directory › RxCUI 2720071

Finerenone 40 MG Oral Tablet [Kerendia] — RxCUI 2720071

RxNorm drug concept · Semantic branded drug
RxCUI 2720071 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2720071
Official nameFinerenone 40 MG Oral Tablet [Kerendia]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKerendia 40 MG Oral Tablet
FDA products mapped3
Package NDCs mapped12
Reported Medicaid activity (SDUD)81,262 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Finerenone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on why your doctor prescribed it. If you have chronic kidney disease and type 2 diabetes, Kerendia is designed to slow down kidney decline and lower your risk of serious...
  • What exactly is Kerendia supposed to do for me?
  • No — you can take Kerendia with or without food, whichever is easier for your routine. Just make sure to take it around the same time each day. If you have trouble swallowing the t...
  • High potassium, called hyperkalemia, is the most important one to know about. Your kidneys help flush out potassium, so if they're not working at full strength, potassium can build...
📖 Read our full Finerenone guide →

🕸️ Concept Web — How Finerenone 40 MG Oral Tablet [Kerendia] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Finerenone 40 MG Oral Tablet [Kerendia] RxCUI 2720071

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Finerenone 2562811
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kerendia 2562817
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Finerenone Oral Tablet 2562815
    • Finerenone Oral Product 2562813
    • Finerenone Pill 2562814
    • Finerenone Oral Tablet [Kerendia] 2562819
    • Kerendia Oral Product 2562820
    • Kerendia Pill 2562821
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Finerenone 40 MG Oral Tablet SCD · 2720069
  • Finerenone 40 MG SCDC · 2720068
  • Finerenone Oral Tablet SCDF · 2562815
  • Finerenone Oral Product SCDG · 2562813
  • Finerenone Pill SCDG · 2562814

Brand-Name Concepts

  • Finerenone 40 MG [Kerendia] SBDC · 2720070
  • Finerenone Oral Tablet [Kerendia] SBDF · 2562819
  • Kerendia Oral Product SBDG · 2562820
  • Kerendia Pill SBDG · 2562821
  • Kerendia BN · 2562817

📦 FDA Products & Package NDCs

3 products · 12 package NDCs
12 package NDCs map to RxCUI 2720071 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50419-0540-01 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-01) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2021-07-09
50419-0540-02 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-02) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2021-07-09
50419-0540-06 10 TABLET, FILM COATED in 1 BLISTER PACK (50419-540-06) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2025-08-23
50419-0540-70 7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-70) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2021-07-09
50419-0541-01 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-541-01) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2021-07-09
50419-0541-02 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-541-02) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2021-07-09
50419-0541-06 10 TABLET, FILM COATED in 1 BLISTER PACK (50419-541-06) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2025-08-23
50419-0541-70 7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-541-70) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2021-07-09
50419-0542-01 30 TABLET in 1 BOTTLE, PLASTIC (50419-542-01) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2025-07-11
50419-0542-02 90 TABLET in 1 BOTTLE, PLASTIC (50419-542-02) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2025-07-11
50419-0542-06 10 TABLET in 1 BLISTER PACK (50419-542-06) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2025-07-11
50419-0542-70 7 TABLET in 1 BOTTLE, PLASTIC (50419-542-70) Kerendia Bayer HealthCare Pharmaceuticals Inc. 2025-07-11
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (12) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.